摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[3-(4-octylphenoxy)-2-oxopropyl]pyrazole-3-carboxylic acid | 1214282-00-4

中文名称
——
中文别名
——
英文名称
1-[3-(4-octylphenoxy)-2-oxopropyl]pyrazole-3-carboxylic acid
英文别名
——
1-[3-(4-octylphenoxy)-2-oxopropyl]pyrazole-3-carboxylic acid化学式
CAS
1214282-00-4
化学式
C21H28N2O4
mdl
——
分子量
372.464
InChiKey
JVXSQOAKSYVQIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    27
  • 可旋转键数:
    13
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    81.4
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    methyl 1-[3-(4-octylphenoxy)-2-oxopropyl]pyrazole-3-carboxylate 、 potassium hydroxide 、 盐酸 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以6%的产率得到1-[3-(4-octylphenoxy)-2-oxopropyl]pyrazole-3-carboxylic acid
    参考文献:
    名称:
    1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase
    摘要:
    Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) and fatty acid amide hydrolase (FAAH) are enzymes, which have emerged as attractive targets for the development of analgetic and anti-inflammatory drugs. We recently reported that 1-[3-(4-octylphenoxy)-2-oxopropyl]indole-5-carboxylic acid (10) and related compounds are inhibitors of cPLA(2)alpha. Since cPLA(2)alpha and FAAH possess several common structural features, we now screened this substance series together with some new derivatives for FAAH inhibition. Some of the assayed compounds proved to be selective cPLA(2)alpha inhibitors, while others showed high FAAH and moderate cPLA(2)alpha inhibitory potency. Furthermore, several derivatives were favorably active against both enzymes and, therefore, could represent agents, which have improved analgetic and anti-inflammatory qualities in comparison with selective cPLA(2)alpha and FAAH inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.11.028
点击查看最新优质反应信息